My crystal ball tells me that Mermaid will be restructuring its capital base very shortly
There is no doubt in my mind, this company's cash outgoings are higher than free cash flow and there will be another impairment substantially higher than last one announced at or before full year results
I agree with some of the posters - shareholders will be seeing another testing of sub 20 cents in script price
Of course above is my opinion based on research and market sensitive announcements by company
MRM Price at posting:
30.5¢ Sentiment: None Disclosure: Not Held